To appear in Best of the Brokers, email your research to email@example.com
Peel Hunt has maintained its “buy” rating, with the target price set at 8.3p. The broker believes Toumaz has a strong pipeline for its wireless vital signs monitoring patch developed by its Sensium Healthcare subsidiary, with good potential to develop high volume sales in the market.
Panmure Gordon has reduced the media group to “sell” from “buy”, cutting the target price to 590p from 940p. The broker thinks the new boss of UBM should cut the dividend and sell PRNewswire, to focus instead on investing more aggressively in its key global events business.